Bliss Aesthetics, which is an AI-driven platform for cosmetic enhancement, announced a $17.5 million seed funding round to grow the platform. Shine Capital led the funding round, followed by Synchrony Ventures, Sheva Ventures, Point72 Ventures, and Cerca Partners.
About 25% of Americans have undergone a medical aesthetic procedure, which is expected to increase by 55% among American men. Utilizing GenAI, Stable Diffusion, and computer vision models, Bliss’ platform enables patients to realistically visualize their cosmetic enhancements and select a board-certified physician who meets their expectations.
This platform also offers information about potential financing partners to create a seamless experience from start to finish. And the platform improves patient engagement from 40% to 80%, allowing doctors to focus on their craft and scale their businesses.
The Bliss Aesthetics platform is available to patients in Florida, Texas, Illinois, Arizona, Michigan, and North Carolina.
KEY QUOTES:
“This funding will give us the ability to harness the momentum we are experiencing, building on the 500% growth of our provider base in our patient-to-physician app since our launch while expanding to five new states across the country. By combining intelligent matchmaking with AI tools, we equip patients to make informed, confident, and financially savvy decisions and give doctors the ability to deliver better outcomes to more patients with less administrative burden.”
- Gal Yosef, Bliss’ Co-Founder and CEO
“Through working firsthand in the industry, I’ve seen the need for a seamless consumer platform like Bliss. For physicians, the next-generation platform streamlines patient management and positions surgeons to deliver more precise patient outcomes and improve satisfaction. It’s simply a game changer for cosmetic and plastic surgery.”
- Celebrity doctor and board-certified plastic surgeon Dr. Michael Salzhauer (also known as Dr. Miami), who co-founded the platform and serves as Chief Medical Officer
“From the moment we met Gal and the Bliss team, we recognized that they had identified a massive market need – for physicians and their patients. We love investing in areas undergoing a radical shift in consumer perceptions and behavior. Cosmetic surgery is an area driven by demographics, and building technology tools to serve patients and providers helps the market develop while ensuring the highest-quality experience. Gal and the Bliss team are poised to create a category-defining technology platform and marketplace in this highly personal and massively growing space.”
- Mo Koyfman, Founder and General Partner at Shine Capital
“Synchrony knows from experience with our own CareCredit network of providers that transparency and access to information is key in the health and wellness industry. This investment is a natural fit for us to support digital innovations that connect patients with knowledge and the ability to finance the care they want and need.”
- Maran Nalluswami, EVP and Chief Strategy and Business Development Officer at Synchrony
